Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer (Q37542524)

20 August 2017

Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer (English)

1 reference

triple-negative breast cancer

20 August 2017

0 references

1 reference

Ana Maria Gonzalez-Angulo

6

object named as

Ana M Gonzalez-Angulo

1 reference

20 August 2017

5

Gabriel N Hortobagyi

1 reference

20 August 2017

Shaheenah Dawood

1

1 reference

20 August 2017

Xiudong Lei

2

1 reference

20 August 2017

Jennifer K Litton

3

1 reference

20 August 2017

Thomas A Buchholz

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

22 February 2012

1 reference

20 August 2017

1 reference

20 August 2017

118

1 reference

20 August 2017

19

1 reference

20 August 2017

4652-4659

1 reference

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

23 August 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Survival among women with triple receptor-negative breast cancer and brain metastases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Breast cancer subtypes and survival in patients with brain metastases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Molecular portraits of breast cancer: tumour subtypes as distinct disease entities

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

CNS metastases in breast cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Molecular portraits of human breast tumours

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Directed therapy of subtypes of triple-negative breast cancer.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Molecular stratification of triple-negative breast cancers.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Primary breast cancer phenotypes associated with propensity for central nervous system metastases

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Central nervous system metastasis from breast carcinoma. Autopsy study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Breast Cancer Metastasis: Challenges and Opportunities

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910255

Estrogen receptor: A prognostic factor in breast cancer

3 December 2018

1 reference

12 December 2020

The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization

1 reference

12 December 2020

Breast cancer: metastatic patterns and their prognosis

1 reference

12 December 2020

Nuclear structure in cancer tissues

1 reference

12 December 2020

Central nervous system metastases in women after multimodality therapy for high risk breast cancer

1 reference

12 December 2020

Survival in patients with brain metastases from breast cancer: the importance of HER-2 status

1 reference

12 December 2020

Defining prognosis for women with breast cancer and CNS metastases by HER2 status

1 reference

12 December 2020

Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.27434

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

22359359

1 reference